Chaperones TAPBPR and tapasin associate with class I major histocompatibility complexes (MHC-I) to promote optimization (editing) of peptide cargo. Here, we use solution NMR to investigate the mechanism of peptide exchange. We identify TAPBPRinduced conformational changes on conserved MHC-I molecular surfaces, consistent with our independently determined X-ray structure of the complex. Dynamics present in the empty MHC-I are stabilized by TAPBPR and become progressively dampened with increasing peptide occupancy. Incoming peptides are recognized according to the global stability of the final pMHC-I product and anneal in a native-like conformation to be edited by TAPBPR. Our results demonstrate an inverse relationship between MHC-I peptide occupancy and TAPBPR binding affinity, wherein the lifetime and structural features of transiently bound peptides control the regulation of a conformational switch located near the TAPBPR binding site, which triggers TAPBPR release. These results suggest a similar mechanism for the function of tapasin in the peptide-loading complex. NATuRE CHEMICAL BIoLoGy | VOL 14 | AUGUST 2018 | 811-820 | www.nature.com/naturechemicalbiology 811
A protective immune response against endogenous antigens generated from infectious agents or tumors is elicited through interactions between α β T-cell receptors (TCRs) on CD8 + cytotoxic T cells and peptide-loaded major histocompatibility complex class I (pMHC-I) molecules displayed on the surface of antigen-presenting cells 1 . Properly conformed pMHC-I is assembled by an intracellular pathway in which loading of the MHC-I nascent chain with high-affinity peptides dictates complex stability, cell surface lifetime, and immunogenicity 2 . Peptide loading and editing is orchestrated by molecular chaperones tapasin and TAPBPR (TAP-binding protein related), which function as peptideexchange catalysts that influence the repertoire of MHC-I displayed antigens at the cell surface [3] [4] [5] [6] [7] . These chaperones have been linked to human disease in which altered expression results in deregulation of the peptide presentation pathway and dampening of T-cellmediated immune responses in the context of cancer, infections, and autoimmune diseases [8] [9] [10] [11] [12] . A number of studies have gleaned key insights into the peptide-editing functions of tapasin (a key component of the peptide-loading complex) and TAPBPR [13] [14] [15] . Although tapasin and TAPBPR share a common function as MHC-I peptide editors, recent data suggest that they have discrete roles in the cell 15 . This is supported by the finding that TAPBPR is unable to compensate for tapasin in situ 16, 17 and elicits distinct effects on the repertoire of displayed peptides 5 , possibly due to differences in MHC-I allelic dependencies between the two chaperones 13 . Furthermore, whereas tapasin is associated with the transporter related to antigen processing (TAP) in the endoplasmic reticulum (ER), TAPBPR does not interact with either TAP or ERp57 (ref. 16 ) and lacks an ER retention motif, and thus its localization is not restricted to the ER. As a result, TAPBPR is also found in the Golgi and can chaperone MHC-I molecules farther along the trafficking pathway 16 . Recently, TAPBPR has been suggested to perform an additional quality control in the peptide-loading pathway by assisting in MHC-I reglycosylation and consequent recycling of improperly conformed molecules to the ER 18 . Despite these important insights, the molecular basis of the peptide-editing function of TAPBPR (and tapasin) remains incompletely characterized.
Recently, two X-ray structures of peptide-deficient complexes between TAPBPR and the murine MHC-I molecules H2-D d and H2-D b were determined at resolutions of 3.4 Å and 3.3 Å, respectively 19, 20 . These studies propose a direct role for a ~3-Å widening of the MHC-I groove at the conserved α 2-1 helix, induced by TAPBPR, for promoting the release of nonoptimal peptides. Complementary biophysical data and molecular dynamics (MD) simulations have suggested a conformational switch role for the α 2-1 helix 'latch' during peptide exchange, both with and without chaperones 13, 21, 22 . Furthermore, a 5.8-Å cryo-electron microscopy (cryoEM) model of the tapasin/MHC-I assembly 23 showed a consistent chaperone/ MHC-I recognition mechanism. However, important mechanistic details concerning recognition of incoming peptides by the chaperoned groove are difficult to visualize crystallographically or by cryoEM. Recent advances in solution nuclear magnetic resonance (NMR) spectroscopy have enabled the characterization of highmolecular-weight protein assemblies of considerable size and dynamic complexity 24 . Here, we utilize these methods to explore the interaction of TAPBPR with MHC-I molecules of varying peptide occupancies and provide new insights into understanding how TAPBPR 'edits' the peptide repertoire. Our results suggest a peptide-exchange mechanism in which a transient pMHC-I-TAPBPR intermediate governs the selection of high-affinity peptides. Based on a range of biophysical data, we propose a model for chaperone release through negative allosteric coupling between nonoverlapping chaperone and peptide binding sites along both ends of the MHC-I groove. Insights derived from our data provide a molecular blueprint for engineering novel molecular chaperones with desired specificities to promote peptide exchange both in vitro and in vivo. 15 N probes revealed by measurement of 15 N-{ 1 H} NOE, R 2 (s −1 ) and R 1 (s −1 ) values recorded at 25 °C at a 1 H field of 600 MHz on H2-D d -labeled P18-I10/H2-D d /hβ 2 m. A diagram of the H2-D d secondary structure is provided for reference. Gray boxes highlight dynamic regions of interest. Striped bars represent protein domains of the MHC-I as observed in the X-ray structure of the H2-D d molecule. The dashed line demarcates rigid parts of the molecule (above the line) from regions of increased mobility, such as loops (below the line), according to the heteronuclear NOE values. b,c, Representative relaxation dispersion curves highlighting methyl groups undergoing chemical exchange (R ex > 1 s −1 ) in 1 H-13 C multiple-quantum CPMG experiments recorded at 25 °C and a 1 H field of 600 MHz. The effective transverse relaxation rate (R 2 eff) is shown as a function of the CPMG pulse frequency (ν CPMG ) for select methyl groups. NMR resonances with measured R ex > 1 s −1 are H2-D d residues V12, V28, L95, V103, L110, L126, A135, A136, A150, L180, L215, L230, L270 and L272, as well as hβ 2 m residues I1, V27, L39, V49, L54, L64, V82 and V85. d, Residues with NMR resonances exhibiting dynamics are indicated on the structure of P18-I10/H2-D d /β 2 m (PDB ID 3ECB) with select residues from a, b, and c labeled, except for C-terminal residues K276/E277, which are not present in the X-ray structure. e, The location of all assigned AILV methyl probes is mapped on the structure of P18-I10/H2-D d /β 2 m (PDB ID 3ECB).
Notably, we find that MHC-I regions of increased flexibility correlate with residues required for TAPBPR association ( Supplementary  Fig. 1 ), supporting a direct role for dynamics in driving recognition of peptide-editing chaperones 13, 21 .
TAPBPR recognition of a peptide-loaded MHC-I molecule.
To evaluate the propensity for TAPBPR to bind H2-D d molecules with distinct peptide occupancies, we used size-exclusion chromatography (SEC) 6 and found that TAPBPR forms a high-affinity complex with either peptide-deficient H2-D d ( Supplementary Fig. 2 ), partially loaded RGPGC-H2-D d S73C or fully loaded P18-I10/ H2-D d ( Supplementary Fig. 3a-c) . Subsequent characterization by NMR reveals a tight complex between pMHC-I ( Supplementary  Fig. 4 ) and TAPBPR in which chemical exchange between the free and bound states is slow on the chemical shift timescale. We observe two types of effects on the H2-D d and hβ 2 m backbone amide and the AILV methyl resonances upon TAPBPR binding: (i) chemical shift deviations (CSDs), indicating a change in the local magnetic environment, and (ii) conformational-exchangeinduced line broadening leading to reduced peak intensity ratios (I/I 0 ), suggesting changes in microsecond-to-millisecond timescale dynamics . Mapping effects onto the pMHC-I structure revealed affected H2-D d sites on the α 1 helix, the α 2 helix, the pleated β -sheet on the floor of the groove, and the α 3 domain at the CD8 binding site (Supplementary Figs. 5a,b, 6a,b and 7a,c). For hβ 2 m, we identified a continuous molecular surface located at the interface with the H2-D d α 3 domain (Supplementary Figs. 5c,d, 6c,d and 7b,d).
To quantitatively characterize binding under conditions in which peptide dissociation from the complex is minimal, we titrated TAPBPR into a 100-μ M pMHC-I sample (labeled at the heavy chain) and performed a rigorous NMR line shape analysis for the resonances of nine methyl probes spanning both TAPBPR binding sites ( Fig. 2a-d ). The two regions are simultaneously and cooperatively engaged by TAPBPR with globally fitted K d and k off values of 32 µ M and 2.9 s −1 , respectively (Supplementary Figs. 5e,f and 6e,f and 10). Notwithstanding our observation of a substantial interaction between TAPBPR and H2-D d loaded with a highaffinity peptide, recognition of peptide-loaded molecules showed a strong MHC allelic dependency. No TAPBPR binding could be detected in experiments using three additional peptide-loaded class I HLA (human leukocyte antigen) molecules, by either SEC (HLA-B*15:01, HLA-B*27:02) or NMR (HLA-A*01:01), suggesting that if there is such an interaction it must be extremely transient (k off ≫ 3 s −1 ). ( Supplementary Figs. 8 and 9 ).
Finally, it remains unclear whether N-linked glycosylation of conserved Asn residues on the MHC-I modulates chaperone association (outside of protein localization to the PLC) 18 . To further explore a potential structural basis for such an interaction, we modeled the Glc1Man9GlcNAc2 glycan, which is recognized by calreticulin 28 , using the putative N-glycan acceptor sites 29 on H2-D d or H2-D b in the two X-ray MHC-I-TAPBPR structures. Although we find no clear overlap between the glycans and TAPBPR by structural modeling ( Supplementary Fig. 11 ), this important aspect of MHC-I recognition by chaperones remains to be addressed in future experiments.
Comparison of solution NMR mapping with X-ray structures.
While NMR experiments were underway, the X-ray structures of the H2-D d S73C -β 2 m-TAPBPR 20 and H2-D b -β 2 m-TAPBPR 19 complexes were solved. In both our NMR experiments and the X-ray structures, the H2-D d α 2-1 helix and the CD8 recognition loop of the α 3 domain are in direct contact with the TAPBPR N-terminal (TN) (N/IgV) and C-terminal (TC) (IgC) domains, respectively ( Fig. 2e-g) . The TAPBPR TC domain is nestled between the H2-D d α 3 domain and β 2 m, which is an unanticipated result and is supported by our NMR experiments ( Fig. 2e,f) . Detailed inspection of MHC-I-TAPBPR contacts within 4 Å in the X-ray structure shows excellent agreement with MHC-I residues undergoing significant chemical shift perturbations in solution ( Fig. 2g ). Thus, independent characterization of the MHC-I-TAPBPR complex crystallographically and by NMR reveals a multifaceted interaction of TAPBPR with both peptide-deficient as well as peptide-loaded MHC molecules.
Modulation of dynamics in MHC-I-TAPBPR complexes.
The electron density corresponding to the peptide atoms is completely missing from the available MHC-I/chaperone structures 19, 20, 23 . To elucidate how peptides influence groove dynamics, we compared the spectra of either peptide-deficient, partially loaded, or fully loaded MHC-I-TAPBPR ( Fig. 3a) . Whereas in the fully loaded complex most methyl groups in the H2-D d groove give rise to wellresolved NMR peaks, in the other complexes several resonances are broadened because of conformational exchange at the intermediate (microsecond to millisecond) timescale ( Fig. 3a,b , left). Notably, when the groove is partially occupied by a disulfide-conjugated pentamer peptide, resonances corresponding to residues in the A, B, C and D pockets become consistently less broadened relative to the unoccupied state, whereas resonances corresponding to residues in the F pocket remain exchange-broadened ( Fig. 3a ,b, middle). This 'rescuing' of attenuated NMR peaks becomes even more pronounced in a complex that is loaded with the full-length P18-I10 peptide, specifically for resonances corresponding to F-pocket residues ( Fig. 3a,b , right). Pairwise comparisons of methyl chemical shift deviations, computed relative to the free pMHC-I reference spectrum, show close agreement between MHC-I-TAPBPR complexes containing different peptides ( Supplementary Fig. 12 ). A difference can be observed at residue I124 ( Supplementary Fig. 12 , right), which we attribute to modulation of dynamics in the α 2-1 helical segment when the adjacent F pocket is unoccupied (RGPGC) or occupied (P18-I10) by peptide ( Fig. 3b ). Analysis of C α distances between representative residues in MD simulations (Methods) reveals that the peptide-deficient groove undergoes a larger range of motions relative to the fully loaded MHC-I molecule and the chaperoned peptide-deficient groove, which is an effect that becomes more pronounced at the C, E and F pockets near the α 2-1 helix ( Fig. 3c ). Taken together, our results suggest that both TAPBPR and incoming peptides dampen the dynamics in the MHC-I groove, culminating in a conformational change within the α 2-1 helix.
NMR reveals a peptide-bound intermediate during exchange.
To probe conformational intermediates along the TAPBPRmediated peptide-exchange pathway, we titrated P18-I10 peptide into a peptide-deficient MHC-I-TAPBPR complex. Initially, specific NMR resonances of residues in the H2-D d groove were attenuated in the absence of peptide, whereas those of residues in the α 3 domain remained observable ( Supplementary Fig. 13a , blue, b-d). Upon the addition of substoichiometric amounts of P18-I10, several exchange-broadened NMR resonances began to appear in either similar (V76) or unique (I124, I142, A153, and A158) chemical shift positions relative to the reference spectrum of the native P18-I10/H2-D d /hβ 2 m molecule ( Supplementary Fig. 13a , purple). This suggests the formation of a peptide-bound intermediate state.
As peptide is incrementally added to achieve a 1:1 molar ratio, the new resonances observed for several methyl groups (I124, I142, and V231) are shifted and attenuated, while a set of resonances corresponding to the chemical shifts of the native pMHC-I reference can be simultaneously observed ( Supplementary Fig. 13a , orange and green). The 'transient' methyl resonances likely arise from an averaging of multiple conformations with distinct chemical shift environments. Their remission into the intermediate exchange NMR regime with increasing peptide concentration and consequent broadening are attributed to a phenomenon previously described as 'transient narrowing' 30 . A complementary LC-MS analysis unambiguously confirms that the 'transient' resonances correlate with the formation of an intermediate state of the MHC-I-TAPBPR complex with peptide captured in the MHC-I groove. Finally, titration of six-fold molar excess of P18-I10 peptide leads to recovery of the reference spectrum, as expected for the formation of the native free pMHC-I species in equilibrium with the TAPBPR-bound form ( Supplementary Fig. 13a , red). The same trend is observed when P18-I10 is titrated onto the RGPGC-H2-D d S73C -hβ 2 m-TAPBPR complex, where addition of the mild reducing agent tris(2-carboxyethyl) phosphine (TCEP) allows complete annealing of P18-I10 and subsequent TAPBPR dissociation ( Supplementary Fig. 14) .
In addition, we compared binding of a suboptimal peptide (photoP18-I10) to the peptide-deficient MHC-I-TAPBPR. PhotoP18-I10 utilizes the same N-and C-terminal anchors as the native P18-I10, but shows a reduced thermal stability in the pMHC-I (Supplementary Table 1 ), presumably due to steric hindrance of the bulky 2-nitrophenyl group and β -amino acid backbone relative to the native valine side chain at position 8 (refs. 6, 31 ; Supplementary Fig. 8a,b . e,f, effects of TAPBPR binding to pMHC-I using solution NMR (with both amide and methyl probes) mapped on the X-ray structure of the H2-D d S73C -β 2 m-TAPBPR complex (PDB ID 5WER). MHC-I: (surface representation, H2-D d green; β 2 m cyan); TAPBPR (cartoon representation, gray). The N-terminal domain (TN) and C-terminal domain (TC) of TAPBPR are noted. Residues with resonances affected in NMR experiments are shown in salmon (H2-D d ) and orange (hβ 2 m). g, Comparison of MHC-I-TAPBPR contacts within 4 Å in the X-ray structure, focusing on the H2-D d α 2-1 helix adjacent to the F pocket. H2-D d residues that are in direct contact in the X-ray structure and affected in NMR experiments are shown in salmon. Supplementary Fig. 15 ). In contrast to P18-I10, photoP18-I10 does not promote TAPBPR dissociation from the MHC-I, even at large molar excess ( Supplementary Fig. 15 ). Taken together, our NMR data suggest that the peptide-deficient MHC-I groove in complex with TAPBPR is sampling multiple conformations, relevant for both peptide recognition and TAPBPR release. Binding of peptide to the empty groove results in the formation of a distinct TAPBPR-bound intermediate state, consistent with our NMR results using purified complexes ( Fig. 2a-c ).
Negative allosteric coupling between peptide and TAPBPR.
To identify peptide features that promote chaperone dissociation, we first screened a range of N-and C-terminal truncations for their efficiency in rescuing the thermal stability of free-peptide-deficient MHC-I molecules prepared using conditional ligands 6,20,31 .
By examining binding of N-and C-terminal deletions of the native ligand P18-I10, we found that a single N-terminal deletion (∆ R1-GPGRAFVTI) can modestly rescue H2-D d thermal stability with a resulting T m of ~44 °C ( Supplementary Table 1 ; Fig. 4a ). The reduced stability is attributed to the loss of Arg1 contacts with Tyr7, Tyr171, and Glu163 in the A and B pockets of H2-D d , resulting in a reduced affinity ( Supplementary Fig. 16a -c and Supplementary Table 2 ). We next used a fluorescence anisotropy (FA) assay to test the binding of different peptides to a chaperoned MHC-I 5,6,32,33 . We added graded concentrations of the peptide-deficient MHC-I-TAPBPR complex to 0.75 nM of a fluorescently labeled peptide (TAMRA-P18-I10), which is readily captured in the MHC-I groove.
( Supplementary Fig. 17a ). We find that an excess of 10 μ M P18-I10 completely outcompetes TAMRA-P18-I10 for binding to the empty groove ( Supplementary Fig. 17b ). Finally, we compared P18-I10, photoP18-I10, and GPGRAFVTI using a similar competition assay. Our results, in terms of the apparent dissociation constants of 0.09, 0.38 and 130 μ M, suggest that peptide/MHC-I interactions spanning the entire groove are critical for TAPBPR-mediated peptide exchange (Fig. 4b) . In both the DSF and FA assays, a negative control peptide, FVTI, showed minimal stability and exchange, as expected. Our FA results are also consistent with surface plasmon resonance (SPR) experiments, in which addition of P18-I10 led to a significant increase in the dissociation rate of TAPBPR from the peptide-occupied groove relative to a peptide-deficient molecule (k off < 0.002 s −1 ). Addition of the suboptimal GPGRAFVTI peptide led to a more modest effect ( Fig. 4c ; Supplementary Fig. 17c,d) .
To further explore how peptides of different lengths may trigger TAPBPR release from the complex, we performed a series of NMR titrations. For P18-I10, we detected the formation of an intermediate state at a 1:1 molar ratio, highlighted by the appearance of methyl resonances corresponding to unique Ile124 and Ile142 conformations ( Fig. 4d , green, red dotted boxes), whereas six-fold molar excess of peptide resulted in detectable formation of the free pMHC-I ( Fig. 4d, red) . Similarly, a titration of GPGRAFVTI shows the intermediate resonances, albeit with significantly attenuated intensities relative to P18-I10, as shown by a comparison of 1 H slices ( Fig. 4e, green) . Accordingly, formation of the final pMHC-I is not detectable by our NMR methyl probes using up to 20-fold molar excess of GPGRAFVTI ( Fig. 4e, red) . A combined NMR, SPR and FA analysis enables a thorough description of the TAPBPR peptideexchange cycle ( Supplementary Fig. 18 ). According to our model, stable capture of a high-affinity peptide in the MHC groove can lead to as much as a three-order of magnitude increase in the dissociation rate of TAPBPR, from 0.002 s −1 to 2.9 s −1 , as observed for P18-I10 (Supplementary Table 3 ). Notably, different peptides show a range of off-rates from the chaperoned MHC groove, from approximately 0.1 s −1 for P18-I10 to > 2 s −1 for the N-terminal deletion mutant.
Finally, to examine specific structural adaptations that occur upon peptide annealing to the chaperoned groove and their role in peptide exchange, we compared methyl NMR spectra of the 'stalled' complex containing GPGRAFVTI to the free P18-I10/H2-D d . Despite the missing N-terminal Arg from the GPGRAFVTI peptide, we measured small CSDs (< 0.1 p.p.m.) for NMR peaks corresponding to residues in the A and B pockets, in contrast to the significant CSDs (0.1 to 0.3 p.p.m.) for peaks corresponding to a continuous surface along the N-terminal α 2-1 helical segment (residues 138-152; Fig. 4f ). This suggests that the conformation of the chaperoned MHC-I groove in the 'stalled' complex is similar to that of the native molecule, with the exception of residues in the D, E and F pockets. This finding is consistent with the sampling of multiple α 2-1 helix conformations in fast exchange while the peptide is bound to the MHC-I-TAPBPR Supplementary Fig. 16c ,d,f, red arrows). Taken together, our results support the view that the chaperoned MHC-I groove selectively captures incoming peptides, and specific structural adaptations are required for TAPBPR dissociation and formation of the final pMHC-I product ( Fig. 4a ; Supplementary Table 1 ). TAPBPR release from the complex is driven by negative allosteric coupling between the peptide binding sites at both ends of the MHC-I groove, the TAPBPR binding site near the α 2-1 helix, and the antiparallel pleated β -sheet underpinning the groove (Fig. 4f ).
The chaperoned groove recognizes peptides in their native conformation. We next titrated 13 C-labeled peptides onto unlabeled, peptide-deficient MHC-I-TAPBPR complexes to explore peptide annealing under conditions in which TAPBPR dissociation from the MHC-I is negligible (according to our previously determined K d of 32 μ M). We found that 13 C methyl and aromatic resonances of P18-I10 show large CSDs when the free peptide is compared to MHC-I and MHC-I-TAPBPR bound states (Fig. 5a,b ). P18-I10 binds in slow exchange, wherein a unique set of peaks corresponding to formation of the pMHC-I-TAPBPR complex can be readily observed. TAPBPR binding only leads to minor additional changes, suggesting that chaperones do not alter the conformation of the MHC-I-bound peptide (Fig. 5a-c) . As expected, we observed significantly reduced binding for the 13 C-labeled GPGRAFVTI peptide, albeit still at the slow exchange NMR regime ( Supplementary Fig. 19a,b) , as highlighted by a peak intensity ratio analysis for all peptide methyl probes obtained at the 1:1 titration point (Fig. 5d) . A detailed NMR line shape analysis suggests that binding is at least 100-fold weaker than that of P18-I10 (> 900 µ M vs. 7.2 µ M, respectively; Fig. 5e and Supplementary  Fig. 19d ). The slow-exchange NMR titration behavior observed for GPGRAFVTI, despite its modest affinity, suggests that peptide binding necessitates k on -limiting structural adaptations in an "induced fit" mechanism 34 . The resonances of the bound states are consistent between P18-I10 and GPGRAFVTI, showing that the two peptides adopt a similar conformation in the intermediate complex with TAPBPR relative to the reference pMHC-I structure ( Supplementary Figs. 19 and 20 ; Supplementary Table 4 ).
Discussion
Despite tapasin and TAPBPR having been discovered more than a decade ago, only recently have structural and mechanistic details of their peptide-editing function begun to emerge 13, 15 . Here, we use solution NMR to directly evaluate the role of structural plasticity and conformational dynamics in mediating peptide exchange. In agreement with the recent X-ray structures 19, 20 , conserved surfaces on the H2-D d heavy chain, including the pleated β -sheet floor of the groove, the α 2-1 helix, and the CD8 recognition loop in the α 3 domain, are used to form a high-affinity interaction with TAPBPR ( Fig. 2e-g) . Our data highlight effects on the α 1 helix opposite from the TAPBPR binding site ( Supplementary Figs. 5e,f and 6e,f) , which further supports a widening of the MHC-I groove at the F pocket ( Supplementary  Fig. 16c-f ). The widening is promoted by a 'Tyr84 swing' , whereby the conserved heavy chain residue Y84 is flipped and hydrogen bonds with TAPBPR E102 (refs. 19, 20 ) . In the absence of TAPBPR, Y84 plays a role in closing of the α 2-1 helix 'latch' by associating with the C terminus of bound peptides in the F pocket 35 . This phenomenon is similar to a 'W43 swing' , which mediates the class II MHC interaction with the DM chaperone 36 . Together, our independent studies of the MHC-I-TAPBPR complex by crystallography and solution NMR allow us to elucidate a detailed mechanism of peptide exchange. Conformational plasticity within the groove of class I and II MHC molecules has been linked to peptide exchange 21, 22 . NMR has provided direct measurements of groove dynamics in peptide-deficient molecules 37 , as well as domain mobility along the β 2 m interface 38 . NMR relaxation dispersion experiments have revealed dynamics of the α 2-1 helix and pleated β -sheet of peptide-loaded molecules, such as HLA-B*35:01 (ref. 39 ), whereas hydrogen/deuterium exchange points to allotypespecific differences in dynamics between peptide-loaded and peptidedeficient MHC-I molecules 40 . Our relaxation dispersion measurements of pMHC-I highlight motions at the α 2-1 helix and pleated β -sheet floor of H2-D d (near the C, E and F pockets) and plasticity at the hβ 2 m/heavy chain interface (Fig. 1d ), consistent with previous NMR results for HLA-B*27 (refs. 38, 41 ) and MD simulations of HLA-B*44 (ref. 42 ). Intriguingly, regions of mobility in the pMHC-I correlate with surfaces required for TAPBPR binding ( Supplementary Fig. 1 ), suggesting a direct role of dynamics in driving chaperone recognition. In particular, the C β methyl of A150, which is located on a linker region between the short α 2-1 and longer α 2-2 helices, undergoes chemical exchange at the ~2 ms timescale, which could arise from a switching between distinct φ /ψ dihedral angles impacting the orientation of the α 2-1 helix (Fig. 1b ) . In our MD simulations, sampling of the 'open' conformation is observed for a highaffinity P18-I10-H2-D d complex, but becomes more pronounced for a peptide-deficient molecule ( Fig. 3c and Supplementary Fig. 16e,f) , which is consistent with similar simulation results reported for other MHC-I alleles 43 . Therefore, in conjunction with previous reports, our data are consistent with a conformational selection mechanism driving the recognition of different pMHC-I molecules by TAPBPR.
Our NMR data provide evidence that peptide-deficient MHC-I-TAPBPR complexes are stable, properly conformed molecules in solution ( Fig. 3a ), in agreement with previous studies describing the stabilization of chaperoned MHC-I molecules in a peptide-receptive conformation 5, 6 . According to our MD simulations, TAPBPR stabilizes the peptide-deficient groove by dampening dynamics within the C, E and F pockets relative to an empty, unchaperoned MHC-I groove ( Fig. 3c and Supplementary Fig. 16e,f) , as previously suggested by simulations of modeled MHC-I-tapasin complexes 44 . Taken together, our results suggest a functional role of chaperones as 'stand-ins' for the peptide in modulating MHC-I groove dynamics, enabling enhanced kinetic and thermal stability 45 .
The available structures of MHC-I-chaperone complexes entirely lack electron density corresponding to peptide 19, 20, 23 . Here, we identify a peptide-bound MHC-I-TAPBPR intermediate state and characterize structural adaptations in the MHC-I upon peptide annealing to the complex. In particular, we find that dynamic motions of the MHC-I groove are progressively reduced as a function of increasing peptide occupancy (Fig. 3a,b ). Crucial contacts in the A and B pockets guide peptide recognition by the chaperoned MHC-I groove, triggering TAPBPR dissociation from the complex (Figs. 4e and 5f ). Our data provide evidence for negative allosteric coupling between the A and F pockets of the MHC-I groove, with the TAPBPR binding site near the α 2-1 helix and the pleated β -sheet underlying the groove. Notably, the TAPBPR-induced widening of the MHC-I groove limits peptide binding to the F pocket ( Fig. 4f and Supplementary Fig. 16c,d,f) . Consequently, while TAPBPR is bound to the MHC-I, initial peptide annealing is dominated by interactions within the A and B pockets, which remain properly conformed in the chaperoned groove. This 'indirect' peptide-sensing model used by chaperones is supported by our observation of a significantly reduced binding between peptidedeficient H2-D d -TAPBPR and GPGRAFVTI, which lacks critical A and B pocket contacts. Notably, a similar peptide-editing mechanism has been observed for the DM chaperone, which induces structural rearrangements at the P1 pocket of empty MHC-II molecules to promote the rapid and specific selection of high-affinity peptides 36 . A putative role for direct peptide sensing by TAPBPR via the 'scoop' loop spanning residues 22-26 (absent in tapasin), for which electron density is present in the H2-D b -TAPBPR but not in the H2-D d -TAPBPR X-ray structure 19, 20 , has been hypothesized, but such effects remain to be rigorously tested in future experiments.
Our results outline a cycle of peptide exchange governed by reversible transitions between ensembles of MHC-I states ( Fig. 6a ; Supplementary Fig. 21a) . Sampling of open and closed conformations at the α 2-1 helix regulates chaperone association and dissociation. Through inducing subtle structural adaptations in the MHC-I groove, TAPBPR shifts the binding free energy landscape of the cellular peptide pool by several orders of magnitude, as illustrated by our results for the H2-D d system (Fig. 6b ). In the ER and Golgi, TAPBPR associates with MHC-I molecules to maintain them in a receptive conformation ( Fig. 6c-f, step 1) . The α 2-1 helix 'latch' remains in a dynamic equilibrium between open and closed conformations, while bound to the chaperone ( Fig. 6c-f, step 1) . TAPBPR performs its peptide-editing function by promoting dissociation of low-and moderate-affinity peptides, thereby preferentially selecting peptides with higher affinities for the chaperoned groove. Low-affinity peptides are completely excluded from the MHC-I-TAPBPR complex (Fig. 6c,  steps 2 and 3) . Moderate-affinity peptides interact transiently with the MHC-I-TAPBPR complex, but fail to promote TAPBPR release because of the lack of crucial A-and B-pocket contacts, which limits their lifetime within the chaperoned groove (fast k off ) (Fig. 6d , steps 2 and 3, and Supplementary Fig. 21b ). In contrast, high-affinity peptides are guided by initial contacts spanning both the A and F pockets to establish a prolonged interaction with the groove, resulting in a constitutive closure of the α 2-1 helix 'latch' , which triggers TAPBPR release from the pMHC-I (Fig. 6e, step 3) . Inside the ER, a competition between these processes occurs simultaneously, where highaffinity peptides are maintained within the chaperoned groove to become part of the displayed antigen repertoire. (Fig. 6f, step 3) .
In summary, we provide a detailed, NMR-based characterization of dynamics of empty and peptide-loaded MHC-I-TAPBPR complexes and elucidate structural adaptions upon formation of a peptide-bound intermediate state in relation to peptide exchange. The shared similarities of structural and functional aspects between TAPBPR and tapasin imply that a similar exchange mechanism is used by tapasin in the peptide-loading complex-a hypothesis that can be readily tested. Future studies on other H2 and HLA alleles with model peptides will expand upon the role of conformational dynamics and allosteric communication in shaping the peptideediting functions of these highly efficient molecular machines.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0096-2.
Protein expression, refolding and purification. DNA encoding the luminal domain of class I MHC (MHC-I) heavy chains H2-D d , HLA-A*01:01, HLA-B*15:01, HLA-B*27:02 and human β 2 m (hβ 2 m, light chain) were provided by D. Long of the NIH Tetramer Core Facility and transformed into Escherichia coli BL21(DE3) (Novagen). Proteins were expressed in Luria Broth, and inclusion bodies were processed as previously described 46 . For in vitro refolding, 10 mg of peptide and 200 mg mixtures of heavy chain:light chain at a 1:3 molar ratio were slowly diluted over 24 h into refolding buffer (0.4 M arginine-HCl, 2 mM EDTA, 4.9 mM reduced l-glutathione, 0.57 mM oxidized l-glutathione, 100 mM Tris pH 8.0) at 4 °C while stirring. Refolding proceeded for 4 d at 4 °C without stirring. Samples in which photoP18-I10 was used were protected from light (except during UV-irradiation) with aluminum foil throughout purification and data acquiring procedures. Purification of pMHC-I complexes was performed by sizeexclusion chromatography (SEC) with a HiLoad 16/600 Superdex 75 pg column at 1 mL/min with running buffer (150 mM NaCl, 25 mM Tris, pH 8), followed by anion exchange chromatography with a mono Q 5/50 GL column at 1 mL/min using a 40 min 0-100% gradient of buffer A (50 mM NaCl, 25 mM Tris, pH 8) and buffer B (1 M NaCl, 25 mM Tris, pH 8). The luminal domain of TAPBPR was expressed as previously described using a Drosophila S2 cell expression system and purified in a similar manner to pMHC-I molecules 6 . The C121S and S73C H2-D d mutants were generated by site-directed mutagenesis and confirmed with DNA sequencing. Refolding and purification of RGPGC-H2-D d S73C -hβ 2 m, a previously described mutant in which a partial peptide is covalented linked to the MHC-I groove through a disulfide bond 19 , was performed with all buffers containing 1 mM dipeptide (Gly-Leu) to improve stability throughout sample preparation. All proteins were exhaustively buffer exchanged into 100 mM NaCl and 20 mM sodium phosphate pH 7.2. Protein concentration was determined using A 280 measurements on a NanoDrop with extinction coefficients estimated with the ExPASy ProtParam tool.
Peptides and mass spectrometry. Unlabeled peptides (≥ 98% purity) were prepared by chemical synthesis (Biopeptek Inc., Malvern, PA, USA or GenScript, Piscataway, NJ, USA). The UV-labile RGPGRAFJ*TI, referred to as photoP18-I10, was derived from P18-I10 (RGPGRAFVTI) 6 and contains a modification with 3-amino-3-(2-nitrophenyl)-propionic acid (J*). The reducing agent labile RGPGC, also derived from P18-I10, contains a modification with a cysteine (underlined C) at position five and truncation of residues A6-I10. Peptide concentration was determined using measurements of A 205 with a NanoDrop with extinction coefficients determined using the Protein Parameter Calculator by Anthis and Clore. Liquid chromatography-mass spectroscopy (LC-MS) was carried out with passage through a Higgins PROTO300 C4 column (5 μ m, 100 mm × 2.1 mm) followed by electron ion spray mass spectroscopy performed on a Thermo Finnigan LC-MS/MS (LTQ). Analysis and deconvolution of LC-MS data was performed with MagTran.
Isotopically labeled peptides were prepared with DNA sequences corresponding to P18-10 (RGPGRAFVTI) or GPGRAFVTI as fusions with an N-terminal immunoglobulin-binding domain of streptococcal protein G (GB1) and a His 6 tag subcloned in pET22b vector. For expression, Escherichia coli BL21(DE3) (Novagen) cells were transformed with plasmid and grown at 37 °C in 1 × M9 minimal media for U-[ 15 N, 13 C] labeling following standard protocols. Expression proceeded with the addition of 1 mM isopropyl β -d-1thiogalactopyranoside (IPTG) at 37 °C, 200 r.p.m. for 5 h. Cell extract was passed through a FF-HisTrap Column (GE Healthcare), and then the His 6 -GB1-peptide construct was solid-phase extracted using a Strata C-18T column (Phenomenex). The protein was resuspended in 50% (v/v) trifluoroacetic acid to perform cyanogen bromide (100-fold molar excess relative to the methionine molar concentration) cleavage overnight. Cleaved peptide was purified by reversed-phase chromatography using an Aeris PEPTIDE XB-C18 column (3.6 µ m, 150 × 4.6 mm, Phenomenex). Peptide identity and purity (≥ 98% purity) was confirmed by MS.
Fluorescence anisotropy. Fluorescence anisotropy (r, herein referred to as FA) was performed using a P18-I10 peptide labeled with TAMRA dye (K TAMRA GPGRAFVTI, herein called TAMRA-P18-I10) (Biopeptek Inc.), which was modeled to not disrupt essential interaction with MHC-I residues compared to the native Arg1. Peptidedeficient H2-D d -hβ 2 m-TAPBPR complexes for FA were prepared by UV-irradiation at 365 nm for 1 h of photoP18-I10-H2-D d /hβ 2 m-TAPBPR complexes as described below. For association experiments, graded concentrations (up to 800 nM) of peptide-deficient H2-D d -hβ 2 m-TAPBPR were added to 0.75 nM TAMRA-P18-I10. For P18-I10 competition experiments, a mixture of 250 nM peptide-deficient H2-D d -hβ 2 m-TAPBPR complex and 0.75 nM TAMRA-P18-I10 was treated with graded concentrations of native P18-I10 ranging from 0 to 75 μ M. Additional peptide competition assays were performed using the same parameters except by adding graded concentrations ranging from 0 to 75 μ M of different peptides (GPGRAFVTI, photoP18-I10, FVTI). All FA experiments were performed in the dark to protect the TAMRA-P18-I10 and photoP18-I10 peptides from photolysis. In the competition experiments, the average FA after incubation with 250 nM peptide-deficient H2-D d -hβ 2 m-TAPBPR for 95-105 min at room temperature (25 °C) was plotted as a function of the log 10 of excess peptide. Each experiment was performed at room temperature in a volume of 100 μ L and loaded onto a black 96-well polystyrene assay plate (Costar 3915). FA data was recorded via a PerkinElmer Envision 2103 plate reader with an excitation filter of λ ex = 531 nm and an emission filter of λ em = 595 nm. Each experiment was performed in triplicate and is representative of at least two independent experiments. Experimental values were subtracted from background FA values obtained from incubation of TAMRA-P18-I10 alone. All samples were prepared in matched buffer (100 mM NaCl, 20 mM sodium phosphate pH 7.2, 0.05% (v/v) tween-20). FA time courses were analyzed by global fitting to the 4-step using DynaFit.
Differential scanning fluorimetry. DSF experiments were performed on an Applied Biosystems ViiA 7 qPCR machine with excitation and emission wavelengths set to 470 nm and 569 nm with proteins in buffer of 100 mM NaCl and 20 mM sodium phosphate, pH 7.2. Experiments were conducted in triplicate in MicroAmp Fast 96-well plates with 50 μ L total volume containing final concentrations of 7 μ M protein and 10 × SYPRO orange dye (Thermo Fisher). For UV-treated samples, proteins were UV-irradiated at 365 nm for 1 h at room temperature and assayed following centrifugation at 13,000 r.p.m. for 10 min to remove precipitates. For reducing-agent-treated samples, samples were incubated with 1 mM TCEP for 1 h and assayed in the presence of TCEP following centrifugation at 13,000 r.p.m. for 10 min to remove precipitates. Rescue experiments were performed by incubation with 20-fold molar excess peptide throughout the duration of the experiment. Temperature was incrementally increased at a scan rate of 1 °C/min between 25 °C and 95 °C. Data analysis and fitting were performed in GraphPad Prism v7.
Preparation of MHC-I-TAPBPR complexes and binding assays.
To prepare peptide-deficient MHC-I-TAPBPR complexes, 200 µ M photoP18-I10/H2-D d /hβ 2 m and ~200 µ M TAPBPR were mixed together (1:1 molar ratio) and incubated for 1 h at room temperature. The mixture was UV-irradiated at 365 nm for 1 h followed by centrifugation at 13,000 r.p.m. for 10 min to remove precipitates. Pure 1:1 stoichiometric MHC-I-TAPBPR complexes were isolated by SEC with a Superdex 200 Increase 10/300 GL column at flow rate 0.5 mL/min in 100 mM NaCl, 20 mM sodium phosphate pH 7.2. For analytical SEC binding assays, 80 µ M pMHC-I and 160 µ M TAPBPR were mixed (1:2 molar ratio) and incubated at room temperature for 1 h. Analytical SEC binding assays were performed using a Superdex 200 Increase 10/300 GL column at flow rate 0.5 mL/min in 100 mM NaCl and 20 mM sodium phosphate, pH 7.2.
Surface plasmon resonance. SPR measurements were performed using a BiaCore T200 (GE Healthcare, Uppsala, Sweden) instrument at 25 °C in 150 mM NaCl, 10 mM HEPES pH 7.3, 3 mM EDTA and 0.05% (v/v) tween-20. Approximately 300 resonance units (RU) of biotinylated TAPBPR was immobilized on a streptavidin-coated chip (GE Healthcare). H2-D d S73C -β 2 m was then captured on the TAPBPR coated surface followed by a 120 s wash-out step with buffer. Graded concentrations of P18-I10 or GPGRAFVTI ranging from 0.5 to 32 µ M were sequentially injected for 120 s, and the dissociation of H2-D d S73C -β 2 m was monitored. The surface was regenerated after each binding and dissociation cycle by injecting 100 µ M P18-I10 to achieve complete dissociation.
Sample preparation for NMR. Samples for NMR were prepared as previously described 47 . Protein expression was achieved by induction with 1 mM isopropyld-thiogalactoside (IPTG) at an OD 600 of 0.6 followed by cell growth at 37 °C for 5 h at 200 r.p.m. Isotopically labeled pMHC-I was buffer exchanged into 100 mM NaCl, 20 mM sodium phosphate pH 7.2, 0.01% (v/v) NaN 3 and 1 U Roche protease inhibitor cocktail in 90% H 2 O/10% D 2 O. MHC-I-TAPBPR complexes for NMR were prepared by mixing 200 µ M isotopically labeled pMHC-I with 200 µ M unlabeled TAPBPR at a 1:1 mol ratio in matched buffer (100 mM NaCl, 20 mM sodium phosphate pH 7.2) followed by isolation of pure 1:1 complex by SEC as described above. Peptide-deficient complexes were prepared as described above using isotopically labeled pMHC-I samples followed by isolation of pure 1:1 complex by SEC. Loss of peptide was confirmed by LC-MS.
NMR chemical shift assignments and dynamic measurements.
Triple-labeled U-[ 15 N, 13 C, 2 H] and AILV side chain methyl (Ala 13 Cβ , Ile 13 Cδ 1, Leu 13 Cδ 1/ 13 Cδ 2, Val 13 Cγ 1/ 13 Cγ 2)-labeled (at either H2-D d or hβ 2 m) pMHC-I molecules were prepared. We used a previously published multipronged assignment approach 47 . Backbone amide resonances were assigned using a standard TROSY-based 3D HNCO, HNCA and HN(CA)CB experiments recorded at 600 MHz at 25 °C. Acquisition times of 30 ms ( 15 N), 20 ms ( 13 CO) and 10/5 ms ( 13 C α / 13 C β ) in the indirect dimension were used. Backbone amide assignments were validated by acquiring amide-amide NOEs using 3D H N -NH N and 3D N-NH N SOFAST NOESY experiments 48 . AILV methyl resonances were assigned using a 3D HMCM[CG] CBCA methyl out-and-back experiment recorded on 1 mM pMHC-I samples at 800 MHz at 25 °C. Acquisition parameters were 80, 80, 1,536 complex points in the 13 C aliphatic , 13 NMR experiments with isotopically labeled peptide. For structure determination of unbound P18-I10 in solution, a sample containing 1 mM P18-I10 (natural isotopic abundance) was used to record a 2D 1 H-1 H NOESY (300 ms mixing time; 75 ms acquisition time in the indirect dimension) spectrum was acquired at a 1 H field of 800 MHz at 4 °C in addition to 2D 1 H-15 N HSQC, 2D 1 H-13 C HSQC spectra, and 2D 1 H-1 H TOCSY spectrum (80 ms isotropic mixing time; 30 ms acquisition time in the indirect dimension) acquired at a 1 H field of 600 MHz at 4 °C. In all experiments the recycle delay was set to 1 s. Automatic NOE assignments and structure calculations were performed in CYANA 2.1 followed by manual inspection and validation. The P18-I10 ensemble was generated from the 20 lowest energy structures (1.51 Å r.m.s. deviation).
NMR spectra of P18-I10 or GPGRAFVTI in the unbound, MHC-I-or MHC-I-TAPBPR-bound states were obtained using 2D 1 H-13 C SOFAST HMQC experiments with selective excitation of either the methyl ( 13 C M -SOFAST HMQC) or aromatic side chain ( 13 C Aro -SOFAST HMQC) resonances as previously described 47 . CSDs and peak intensity ratios analysis was performed as described above. For peptide titration experiments, 113.6 μ M of unlabeled peptidedeficient H2-D d -hβ 2 m-TAPBPR complex was titrated with 1.2, 5.7, 28.4, 79.8, 113.6, 227.2 and 340.8 μ M of 13 C-labeled peptide. Each sample was prepared in matched NMR buffer, and experiments were acquired with 2D 1 H-13 C SOFAST HMQC experiments using identical parameters with methyl probes as a readout. Experiments were performed at 25 °C at a 1 H field of 800 MHz. NMR line shape fitting was performed in Integrative Data Analysis Platform (IDAP, available from E. Kovrigin, http://lineshapekin.net/#IDAP) 30 . Data were processed with an exponential window function with 4 Hz and 10 Hz Lorentzian line broadening in the direct and indirection dimensions, respectively. The 13 C dimension from 2D 1 H-13 C SOFAST HMQC spectra was extracted, NMR peaks were normalized to unity area, and fit to a 'U' model corresponding to a two-state binding mechanism with an adjustable constant vertical offset for each spectrum in MATLAB. Error bars represent noise r.m.s. deviation in each spectrum. NMR line shape fitting allows estimation of the upper and lower bounds for the K d and K off .
An apparent K d of each peptide for MHC-I-TAPBPR complex was also determined by calculating the fraction peptide bound (ƒ b -the intensity of the bound NMR peak divided by the sum of the intensities of the bound and free peaks). Titration points were fit to the equation:
[ 
Molecular dynamics simulations.
All-atom molecular dynamics (MD) simulations in explicit solvent were carried out as previously described for MHC-I-tapasin complexes 44 in GROMACS version 5.1.4 using an AMBER99SB-ILDN protein forcefield and TPI3P water model. LINCS and SETTLE constraint algorithms were used to constrain peptide/protein and water molecules, respectively. An integration time step of 4 fs was used with coordinates output every 10 ps. Short range interactions were treated with a Verlet cutoff scheme with 10 Å electrostatic and van der Walls cutoffs and long-range electrostatics were treated with the PME method with a grid spacing of 1.2 Å and cubic interpolation. Periodic dodecahedron boundaries were used. The thermodynamic ensemble was nPT where temperature was kept constant at 300 K by a V-rescale modified thermostat with 0.1 ps time constant and pressure was kept constant at 1 bar pressure using an isotropic Berendsen barostat with 0.5 ps time constant and 4.5 × 10 −5 bar −1 isothermal compressibility. X-ray structures served as inputs: empty H2-D d S73C -β 2 m-TAPBPR (PDB ID 5WER), P18-I10/ H2-D d /β 2 m (PDB ID 3ECB) and empty H2-D d /β 2 m (PDB ID 3ECB modified such that the atoms corresponding to P18-I10 were removed) with missing densities built in using Rosetta. The system was solvated to overall neutral charge and contained Na + and Cl − ions to yield physiological concentration of 0.15 M. Final systems ranged from ~95,000 (empty MHC-I) to 196,000 (empty MHC-I-TAPBPR complex) atoms. Following 500 steps of steepest-descent energy minimization, initial velocities were generated at 65 K with linear heating up to 300 K over 2 ns. Trajectories for each molecule were acquired for 500 ns. Heat maps of the variance of distances between C α atoms of pairs of residues spanning the groove were generated using the heatmapper plugin in VMD. Structures were extracted after the final 500 ns simulation using VMD. 
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